Literature DB >> 23623029

Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patients.

Patrick Coit1, Matlock Jeffries, Nezam Altorok, Mikhail G Dozmorov, Kristi A Koelsch, Jonathan D Wren, Joan T Merrill, W Joseph McCune, Amr H Sawalha.   

Abstract

Systemic lupus erythematosus is an autoimmune disease characterized by multi-system involvement and autoantibody production. Abnormal T cell DNA methylation and type-I interferon play an important role in the pathogenesis of lupus. We performed a genome-wide DNA methylation study in two independent sets of lupus patients and matched healthy controls to characterize the DNA methylome in naïve CD4+ T cells in lupus. DNA methylation was quantified for over 485,000 methylation sites across the genome, and differentially methylated sites between lupus patients and controls were identified and then independently replicated. Gene expression analysis was also performed from the same cells to investigate the relationship between the DNA methylation changes observed and mRNA expression levels. We identified and replicated 86 differentially methylated CG sites between patients and controls in 47 genes, with the majority being hypomethylated. We observed significant hypomethylation in interferon-regulated genes in naïve CD4+ T cells from lupus patients, including IFIT1, IFIT3, MX1, STAT1, IFI44L, USP18, TRIM22 and BST2, suggesting epigenetic transcriptional accessibility in these genetic loci. Indeed, the majority of the hypomethylated genes (21 out of 35 hypomethylated genes) are regulated by type I interferon. The hypomethylation in interferon-regulated genes was not related to lupus disease activity. Gene expression analysis showed overexpression of these genes in total but not naïve CD4+ T cells from lupus patients. Our data suggest epigenetic "poising" of interferon-regulated genes in lupus naïve CD4+ T cells, argue for a novel pathogenic implication for abnormal T cell DNA methylation in lupus, and suggest a mechanism for type-I interferon hyper-responsiveness in lupus T cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23623029      PMCID: PMC3790645          DOI: 10.1016/j.jaut.2013.04.003

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  17 in total

1.  Shared relationship analysis: ranking set cohesion and commonalities within a literature-derived relationship network.

Authors:  Jonathan D Wren; Harold R Garner
Journal:  Bioinformatics       Date:  2004-01-22       Impact factor: 6.937

Review 2.  Epigenetics and T-cell immunity.

Authors:  Amr H Sawalha
Journal:  Autoimmunity       Date:  2008-05       Impact factor: 2.815

3.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.

Authors:  P L Jones; G J Veenstra; P A Wade; D Vermaak; S U Kass; N Landsberger; J Strouboulis; A P Wolffe
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

4.  Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Int J Clin Rheumtol       Date:  2011-08

Review 5.  Interferon alpha as a primary pathogenic factor in human lupus.

Authors:  Timothy B Niewold
Journal:  J Interferon Cytokine Res       Date:  2011-09-16       Impact factor: 2.607

Review 6.  Type I interferon and systemic lupus erythematosus.

Authors:  Keith B Elkon; Vivian V Stone
Journal:  J Interferon Cytokine Res       Date:  2011-08-22       Impact factor: 2.607

7.  Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus.

Authors:  Matlock A Jeffries; Mikhail Dozmorov; Yuhong Tang; Joan T Merrill; Jonathan D Wren; Amr H Sawalha
Journal:  Epigenetics       Date:  2011-05-01       Impact factor: 4.528

8.  Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse.

Authors:  Kristi A Koelsch; Ryan Webb; Matlock Jeffries; Mikhail G Dozmorov; Mark Barton Frank; Joel M Guthridge; Judith A James; Jonathan D Wren; Amr H Sawalha
Journal:  J Autoimmun       Date:  2013-02-18       Impact factor: 7.094

9.  Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo.

Authors:  Silvia N Kariuki; Kyriakos A Kirou; Emma J MacDermott; Lilliana Barillas-Arias; Mary K Crow; Timothy B Niewold
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

10.  A polymorphism within IL21R confers risk for systemic lupus erythematosus.

Authors:  Ryan Webb; Joan T Merrill; Jennifer A Kelly; Andrea Sestak; Kenneth M Kaufman; Carl D Langefeld; Julie Ziegler; Robert P Kimberly; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Michelle Petri; John D Reveille; Graciela S Alarcón; Luis M Vilá; Marta E Alarcón-Riquelme; Judith A James; Gary S Gilkeson; Chaim O Jacob; Kathy L Moser; Patrick M Gaffney; Timothy J Vyse; Swapan K Nath; Peter Lipsky; John B Harley; Amr H Sawalha
Journal:  Arthritis Rheum       Date:  2009-08
View more
  124 in total

1.  The challenge of treating orphan disease.

Authors:  Carlos Dias; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

2.  IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus.

Authors:  Ming Zhao; Yin Zhou; Bochen Zhu; Mengjie Wan; Tingting Jiang; Qiqun Tan; Yan Liu; Juqing Jiang; Shuaihantian Luo; Yixin Tan; Haijing Wu; Paul Renauer; Maria Del Mar Ayala Gutiérrez; Maria Jesús Castillo Palma; Rafaela Ortega Castro; Concepción Fernández-Roldán; Enrique Raya; Raquel Faria; Claudia Carvalho; Marta E Alarcón-Riquelme; Zhongyuan Xiang; Jinwei Chen; Fen Li; Guanghui Ling; Hongjun Zhao; Xiangping Liao; Youkun Lin; Amr H Sawalha; Qianjin Lu
Journal:  Ann Rheum Dis       Date:  2016-01-19       Impact factor: 19.103

3.  Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus.

Authors:  Amr H Sawalha; Susan Manzi
Journal:  Eur J Rheumatol       Date:  2020-04-08

4.  Types of DNA methylation status of the interspersed repetitive sequences for LINE-1, Alu, HERV-E and HERV-K in the neutrophils from systemic lupus erythematosus patients and healthy controls.

Authors:  Patadon Sukapan; Paramate Promnarate; Yingyos Avihingsanon; Apiwat Mutirangura; Nattiya Hirankarn
Journal:  J Hum Genet       Date:  2014-01-16       Impact factor: 3.172

5.  Epigenomic elements enriched in the promoters of autoimmunity susceptibility genes.

Authors:  Mikhail G Dozmorov; Jonathan D Wren; Marta E Alarcón-Riquelme
Journal:  Epigenetics       Date:  2013-11-08       Impact factor: 4.528

Review 6.  Autoimmunity in 2013.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

7.  Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.

Authors:  Nezam Altorok; Pei-Suen Tsou; Patrick Coit; Dinesh Khanna; Amr H Sawalha
Journal:  Ann Rheum Dis       Date:  2014-05-08       Impact factor: 19.103

Review 8.  DNA methylation alterations in the pathogenesis of lupus.

Authors:  S H Chen; Q L Lv; L Hu; M J Peng; G H Wang; B Sun
Journal:  Clin Exp Immunol       Date:  2016-11-01       Impact factor: 4.330

Review 9.  Genetics of human lupus nephritis.

Authors:  Taro Iwamoto; Timothy B Niewold
Journal:  Clin Immunol       Date:  2016-09-28       Impact factor: 3.969

10.  CD3Z hypermethylation is associated with severe clinical manifestations in systemic lupus erythematosus and reduces CD3ζ-chain expression in T cells.

Authors:  Kyeong-Man Hong; Hyun-Kyoung Kim; Seong-Yeol Park; Shiv Poojan; Mi-Kyung Kim; Joohon Sung; Betty P Tsao; Jennifer M Grossman; Ornella J Rullo; Jennifer M P Woo; Deborah K McCurdy; Lisa G Rider; Frederick W Miller; Yeong-Wook Song
Journal:  Rheumatology (Oxford)       Date:  2017-03-01       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.